0001209191-22-030983.txt : 20220520
0001209191-22-030983.hdr.sgml : 20220520
20220520161110
ACCESSION NUMBER: 0001209191-22-030983
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220520
DATE AS OF CHANGE: 20220520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA
CENTRAL INDEX KEY: 0001270734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 22947704
MAIL ADDRESS:
STREET 1: 160 BOVET ROAD, SUITE 408
STREET 2: C/O DELPHI VENTURES
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-19
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001270734
PAKIANATHAN DEEPIKA
C/O DELPHI VENTURES, 63 BOVET RD.
SUITE 351
SAN MATEO
CA
94402
1
0
0
0
Nonstatutory Stock Option (right to buy)
5.65
2022-05-19
4
A
0
23900
0.00
A
2032-05-18
Common Stock
23900
23900
D
This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc.
/s/ Matthew T. Potter, Attorney-in-Fact for Deepika Pakianathan
2022-05-20